Company
Headquarters: Changsha, China
Employees: 911
CN¥10.50 Billion
CNY as of July 1, 2024
US$1.44 Billion
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $154.23 B |
| EssilorLuxottica SA | $98.99 B |
| Becton, Dickinson and Company | $65.82 B |
| Alcon Inc. | $43.72 B |
| HOYA Corp | $42.76 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Sansure Biotech, Inc. has the following listings and related stock indices.
Stock: SSE: 688289 wb_incandescent